Application

18500831 · COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY

Filed 2023-11-02 · Abandoned The official file ↗ · Art unit 1642 · Examiner Laura B Goddard Typical · CPC A61K 39/39533 · Bristol-Myers Squibb Company · HENRY HADAD

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

17.5 mo

to disposition 24.5 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.